XML 65 R14.htm IDEA: XBRL DOCUMENT
v3.25.4

Reverse Recapitalization and Pre-Closing Financing | 12 Months Ended
--- | ---
Dec. 31, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] |
Reverse Recapitalization and Pre-Closing Financing | 4. Reverse Recapitalization and Pre-Closing Financing As described within the Reverse Recapitalization and Pre-Closing Financing section in Note 1, on June 13, 2025, the reverse recapitalization between Pre-Merger Crescent and GlycoMimetics was consummated. The Merger was accounted for as a reverse recapitalization in accordance with U.S. GAAP. At the effective time of the Merger, substantially all of the assets of GlycoMimetics consisted of cash and other nominal non-operating assets and liabilities. No goodwill or intangible assets were recognized. As part of the recapitalization, the Company acquired the assets and liabilities listed below (in thousands):
| As of June 13, 2025
Cash | $ | 1,269 |
Prepaid expenses and other assets | 1,710 |
Accounts payable | (1,303) |
Accrued expenses | (1,151) |
Net assets acquired | $ | 525 |

X
- Definition Reverse Recapitalization And Pre-Closing Financing + References No definition available. + Details
Name: | cbio_ReverseRecapitalizationAndPreClosingFinancingTextBlock
Namespace Prefix: | cbio_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationAndAssetAcquisitionAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration